#1 Clinical Trials Search in Europe

Amiloride Hydrochloride Dihydrate

Amiloride Hydrochloride Dihydrate, a medication traditionally used as a diuretic, is currently being studied in clinical trials for its potential benefits in treating chronic kidney disease and preventing migraine aura. These trials aim to explore new applications of this drug beyond its conventional use, offering hope for patients with these conditions. This article will provide an overview of the ongoing research and what it could mean for future treatments.

Table of Contents

What is Amiloride Hydrochloride Dihydrate?

Amiloride Hydrochloride Dihydrate, commonly known as amiloride, is a medication that belongs to a class of drugs called potassium-sparing diuretics. It is primarily used to treat high blood pressure and heart failure. However, recent research has shown that amiloride may have additional beneficial effects in treating other conditions.[1][2]

Medical Uses of Amiloride

Amiloride is currently being studied for its potential benefits in treating various medical conditions. The two main areas of research focus on:

  • Chronic Kidney Disease (CKD): Researchers are investigating whether amiloride can help slow down the progression of CKD and protect kidney function.[1]
  • Migraine with Aura: Studies are being conducted to determine if amiloride can prevent migraine auras and reduce the frequency of migraine attacks.[2]

Amiloride and Chronic Kidney Disease

A clinical trial is currently underway to explore the potential benefits of amiloride for patients with Chronic Kidney Disease (CKD). The study aims to investigate whether amiloride can help preserve kidney function and reduce the risk of cardiovascular problems in CKD patients.[1]

Key points about the CKD study:

  • The research focuses on patients with eGFR (estimated glomerular filtration rate) between 25 and 60 mL/min/1.73m2. This is a measure of kidney function, with lower numbers indicating reduced kidney function.
  • Participants must have a UACR (urine albumin-to-creatinine ratio) of 300mg/g or higher, which indicates significant protein in the urine, a sign of kidney damage.
  • The study will examine how amiloride affects tubular complement activation and renal interstitial inflammation. These are complex processes involved in kidney damage that researchers believe amiloride might help reduce.

Amiloride for Migraine with Aura

Another ongoing clinical trial is investigating the use of amiloride in preventing migraine auras. Migraine with aura is a type of headache where people experience sensory disturbances (like seeing flashing lights) before or during the headache.[2]

Key aspects of the migraine study:

  • The study focuses on patients who experience at least one migraine with aura per month.
  • Researchers are investigating whether amiloride can reduce the number of migraine attacks with aura.
  • The study will also look at amiloride’s effect on the frequency of migraine headaches overall, as well as its impact on patients’ quality of life and emotional well-being.

Dosage and Administration

In both studies, amiloride is administered orally in the form of tablets. The dosage may vary depending on the specific study and condition being treated:

  • For the CKD study, the maximum daily dose is 10 mg, with a total treatment period of up to 7 days.[1]
  • In the migraine study, the maximum daily dose is also 10 mg, but the treatment period extends up to 3 months.[2]

It’s important to note that these dosages are specific to the clinical trials and may differ from standard prescriptions. Always follow your doctor’s instructions when taking any medication.

Potential Side Effects and Precautions

As with any medication, amiloride may cause side effects. Some potential concerns include:

  • Elevated potassium levels: Amiloride can increase potassium levels in the blood, which can be dangerous for some people.
  • Dehydration: As a diuretic, amiloride increases urine production, which could lead to dehydration if not managed properly.
  • Interactions with other medications: Amiloride may interact with certain other drugs, particularly other diuretics and medications that affect potassium levels.

Always inform your healthcare provider about all medications you’re taking before starting amiloride.

Who Can Take Amiloride?

Eligibility for amiloride treatment may vary depending on the condition being treated. Based on the clinical trials, some general guidelines include:

  • Adults aged 18 and older
  • For CKD treatment: Patients with specific kidney function measurements and stable blood pressure
  • For migraine prevention: Patients diagnosed with migraine with aura, experiencing at least one attack per month

However, certain conditions may prevent someone from taking amiloride, including:

  • High potassium levels in the blood
  • Severe kidney or liver problems
  • Pregnancy or breastfeeding
  • Certain heart conditions
  • Known allergy to amiloride or its components

Always consult with your healthcare provider to determine if amiloride is appropriate for your specific situation.

Aspect Chronic Kidney Disease Trial Migraine with Aura Trial
Main Objective Evaluate Amiloride’s renoprotective effects Assess Amiloride’s efficacy in migraine aura prophylaxis
Key Inclusion Criteria eGFR ≥ 25 but < 60mL/min/1.73m2, UACR ≥ 300mg/g At least 1 migraine attack with aura per month
Primary Endpoint Urine soluble C5-9-sTCC/MAC Number of seizures with aura
Dosage Max daily dose: 10mg, Max total dose: 70mg Max daily dose: 10mg, Max total dose: 900mg
Treatment Duration 7 days 3 months
Key Exclusion Criteria Use of other K-sparing diuretics, organ transplantation Contraindications to Amiloride, pregnancy

FAQ

  • What conditions are being studied in these clinical trials using Amiloride Hydrochloride Dihydrate? The clinical trials are studying the effects of Amiloride Hydrochloride Dihydrate on chronic kidney disease (CKD) and migraine with aura.
  • How might Amiloride help patients with chronic kidney disease? Researchers believe Amiloride may have renoprotective effects by inhibiting urokinase-type plasminogen activator (uPA), which could help preserve kidney function and reduce cardiovascular risks in CKD patients.
  • What is the potential benefit of Amiloride for migraine patients? The study aims to evaluate Amiloride's effectiveness in preventing migraine aura and reducing the frequency of migraine attacks, potentially offering a new prophylactic treatment option.
  • Who can participate in these clinical trials? Eligibility varies, but generally includes adults with either chronic kidney disease (eGFR ≥ 25 but < 60mL/min/1.73m2) or diagnosed migraine with aura (at least 1 attack per month). Specific inclusion and exclusion criteria apply for each trial.
  • What are the main outcomes being measured in these trials? For the CKD trial, primary outcomes include urine complement activation markers. For the migraine trial, the main outcome is the number of migraine attacks with aura. Both trials also measure various secondary outcomes related to disease progression and patient well-being.

Ongoing Clinical Trials on Amiloride Hydrochloride Dihydrate

  • Study on the Effects of Amiloride in Patients with Chronic Kidney Disease

    Recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

  • Study of Amiloride tablets for prevention of migraine with aura attacks

    Recruiting

    4 1 1
    Investigated drugs:
    France

Glossary

  • Amiloride Hydrochloride Dihydrate: A medication primarily used as a potassium-sparing diuretic, now being studied for potential benefits in chronic kidney disease and migraine prevention.
  • Chronic Kidney Disease (CKD): A condition characterized by gradual loss of kidney function over time, which can lead to complications if left untreated.
  • eGFR: Estimated Glomerular Filtration Rate, a measure of kidney function used to determine the stage of chronic kidney disease.
  • UACR: Urine Albumin-to-Creatinine Ratio, a test used to detect kidney damage by measuring the amount of albumin in urine.
  • Renoprotective: Having a protective effect on the kidneys, helping to preserve their function and prevent further damage.
  • Urokinase-type plasminogen activator (uPA): An enzyme involved in breaking down blood clots, which may play a role in kidney damage in CKD patients.
  • Migraine with Aura: A type of migraine headache preceded or accompanied by sensory disturbances (aura) such as flashes of light, blind spots, or tingling in the hands or face.
  • ASIC-1 channel: Acid-Sensing Ion Channel 1, a protein involved in pain sensation that may play a role in migraine development.
  • Prophylaxis: Preventive treatment designed to guard against the development or progression of a disease or condition.
  • HIT-6 scale: Headache Impact Test, a tool used to measure the impact of headaches on daily life and function.
  • HAD scale: Hospital Anxiety and Depression scale, used to assess emotional impact and mental health in patients.
  • EQ-5D scale: A standardized instrument used to measure health-related quality of life.

References

  1. http://clinicaltrials.eu/trial/study-on-the-effects-of-amiloride-in-patients-with-chronic-kidney-disease/
  2. http://clinicaltrials.eu/trial/study-on-amiloride-for-preventing-migraine-aura-in-patients-with-migraine/